12:55 EDT Nuvation Bio (NUVB) trading halted, news pending
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NUVB:
- FDA announces apporval of Nuvation Bio’s Ibtrozi for lung cancer
- Nuvation kinase inhibitor wins FDA approval in non-small cell lung cancer
- Nuvation Bio jumps 4% to $2.64 after FDA approves Ibtrozi
- Nuvation Bio’s Strategic Positioning and Potential FDA Approval: Analyst Recommends Buy Rating
- Nuvation Bio Holds Successful Annual Meeting 2025